NCT06179433

Brief Summary

Background Root canal therapy is the primary treatment of choice for necrotic mature teeth with periapical lesions (PRLs), which does not restore the tooth's vitality. Provided that injectable platelet-rich fibrin (i-PRF) has shown promising results in regenerative medicine as a novel platelet concentration, the purpose of this study is to ascertain whether i-PRF, as opposed to blood clot (BC), can serve as a biological scaffold, thereby expanding the indications for regenerative endodontic procedures (REPs) in mature teeth. Novelty There is no study available that has evaluated the outcome of REP in the necrotic mature mandibular molars with periapical lesions. Furthermore, the efficacy of novel i-PRF as a scaffold in REPs remains to be explored. Objectives To evaluate and compare the outcome of REPs in comparison to conventional RCT in necrotic mature molars with PRLs and to evaluate the efficacy of i-PRF and BC in REP as a scaffold. Secondary objective is to evaluate pain for first postoperative week and subjective responses to pulp sensibility tests at 12 months follow-up. Method 120 patients presenting with necrotic pulp and periapical lesions will be randomly allotted to one of the three groups - REP using i-PRF or BC or RCT group. Comparative evaluation of outcome of REP and RCT will be performed at 12-months follow-up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 21, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

December 21, 2023

Status Verified

December 1, 2023

Enrollment Period

1.3 years

First QC Date

December 12, 2023

Last Update Submit

December 12, 2023

Conditions

Keywords

regenerative endodontics, root canal treatment

Outcome Measures

Primary Outcomes (1)

  • clinical and radiographic success

    Clinical and radiographic success of REPs in comparison to conventional RCT in necrotic mature molars with PRLs

    12 month follow-up.

Secondary Outcomes (2)

  • postoperative pain

    1 week

  • Pulp sensibility response

    6 and 12 months

Study Arms (3)

root canal treatment

EXPERIMENTAL

Two-visit root canal treatment will be performed.

Procedure: Root canal treatment

REP with I-PRF

ACTIVE COMPARATOR

The first appointment will be performed similar to the conventional RCT group. in the second appointment, i-PRF will be prepared by collecting venous blood and centrifugate at 700rpm for 3 minutes. i-PRF will be injected into canal followed by a bioceramic material.

Procedure: Regenerative endodontic procedure

REP with blood clot

ACTIVE COMPARATOR

The first appointment will be performed similar to the conventional RCT group. In the second appointment, after anesthetizing with 3% mepivacine, the canals will be re-entered and irrigated well with 17% EDTA. Bleeding will be induced by inserting sterile #25 K-file into the 2-3 mm beyond the apical foramen into periapical tissues.

Procedure: Regenerative endodontic procedure

Interventions

Two-visit root canal treatment will be performed.

root canal treatment

Regenerative endodontic procedure with i-PRF and blood clot induction will be performed.

REP with I-PRFREP with blood clot

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Consenting healthy adults with age range of 18- 40 years
  • Patient presenting with atleast one permanent mandibular molar with necrotic pulp (negative response to sensibility testing by cold and electric pulp test).
  • Radiographic evidence of periapical radiolucency of strictly endodontic origin score ≥3 according to the classification of Ørstavik et al (diagnosis of asymptomatic apical periodontitis or chronic apical abscess) with lesion size ≤ 5mm

You may not qualify if:

  • Non-restorable teeth or tooth with severe coronal defect where rubber dam isolation is not possible
  • Teeth with root fractures or pathological root resorptions
  • Teeth with endodontic- periodontal communications
  • Patients with generalized chronic periodontitis or periodontal pocket more than 3 mm
  • Teeth with previous root canal treatment
  • Severe root canal curvatures
  • Pregnant or lactating women
  • Patients with a history of systemic diseases and/or receiving medications that affect healing or blood coagulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

postgraduate Institute of Dental sciences

Rohtak, Haryana, 124001, India

Location

MeSH Terms

Conditions

Periapical Periodontitis

Condition Hierarchy (Ancestors)

Periapical DiseasesJaw DiseasesStomatognathic DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Study Officials

  • jigyasa 1 duhan, MDS

    PGIDS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2023

First Posted

December 21, 2023

Study Start

May 1, 2023

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

December 21, 2023

Record last verified: 2023-12

Locations